This image is not available for purchase in your country.

Bevacizumab cancer treatment

Bevacizumab cancer treatment

M625/1716

Rights Managed

This image is not available for purchase in your country.

Please contact your Account Manager if you have any query.

Credit

BSIP, LOUISE OLIGNY / SCIENCE PHOTO LIBRARY BSIP, LOUISE OLIGNY / SCIENCE PHOTO LIBRARY

Caption

Bevacizumab. Doctor drawing a syringe of bevacizumab (Avastin), a monoclonal antibody used in metastatic cancer treatment; for cancers that have spread beyond their original site. It works by targetting and inhibiting the vascular endothelial growth factor (VEGF), thereby preventing tumour growth by blocking the formation of new blood vessels (angiogenesis). Photographed in France.

Release details

Model release not available. Property release not required.

 {{ i.shot_duration ? i.shot_duration + ' ' : '' }}{{ i.shot_uhd ? '4K ' : i.hires ? 'HD ' : '' }}{{ i.spl_number }} R{{ i.license }}

  • Add to board
  • Similar {{ mediaType(i) }}